Position in VRTX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$478,690
-$170,974 QoQ
Shares Held
1,072
-25.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RENAISSANCE GROUP LLC holds $57,437,743 across 5 Biotechnology names. VRTX ranks #5 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
471,499 | $30,472,980 | |
| 2 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
445,215 | $11,023,523 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
51,168 | $9,673,310 | |
| 4 | ADMA |
Adma Biologics, Inc.
|
642,535 | $5,789,240 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
1,072 | $478,690 |
All Filings in VRTX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $478,690 | 1,072 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $649,664 | 1,433 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $574,927 | 1,468 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $676,258 | 1,519 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $830,981 | 1,714 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,281,391 | 3,182 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,499,417 | 3,224 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $34,441,076 | 73,479 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $32,477,704 | 77,696 | Shares | Defined | 2024-04-26 | |
| 2023-12-31 | $36,185,541 | 88,932 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $32,086,317 | 92,271 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $33,055,258 | 93,931 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $30,137,705 | 95,654 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $27,608,523 | 95,604 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $27,897,758 | 96,352 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $29,945,259 | 106,268 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $35,310,806 | 135,306 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $27,475,254 | 125,115 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $21,558,201 | 118,850 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $20,462,420 | 101,485 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $22,902,976 | 106,580 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $19,626,146 | 83,042 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $21,468,635 | 78,894 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $23,074,709 | 79,483 | Shares | Defined | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||